neovascular glaucoma: Neovascular glaucoma is the most common type of secondary glaucoma, usually caused by diabetic retinopathy, central retinal vein occlusion and carotid artery obstruction but sometimes by trauma, uvietis or ocular tumors, and characterized by severe eye pain, synechial angle glaucoma, high intraocular pressure and leading to loss of vision.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1554 |
4. Check minimum number of eventsNone |
1554 |
5. Include endpointsNone |
1554 |
6. Filter based on genotype QC (FinnGen only) |
1554 |
Control definitions (FinnGen only)
- Control exclude
- DM_RETINOPATHY
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H40
- Name in latin
- Glaucoma [secundarium] post aliam morbositatem oculi
Similar endpoints
↥List of similar endpoints to
Neovascular glaucoma
based on the number of shared cases.
Similar with more cases:
- Glaucoma secondary to other eye disorders
- Glaucoma
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 13210 | 6427 | 6667 |
| Only index persons | 11515 | 5648 | 5867 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.18 | 0.18 | 0.19 |
| Only index persons | 0.22 | 0.21 | 0.22 |
| Median age at first event (years) | |||
| Whole population | 69.00 | 71.81 | 66.26 |
| Only index persons | 67.58 | 70.30 | 64.96 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1554 | 716 | 838 |
| Unadjusted period prevalence (%) | 0.31 | 0.24 | 0.37 |
| Median age at first event (years) | 63.75 | 60.19 | 66.79 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1412
- Matched controls
- 14120
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S01ED51
ATC
timolol, combinations; ophthalmic
80.9
323.0
1106
602
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
4503599627370496.0
323.0
1411
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
11.5
323.0
1108
3396
Z96.1
ICD-10 Finland
Presence of intraocular lens
12.9
323.0
723
1060
S01ED01
ATC
timolol; ophthalmic
34.1
323.0
562
268
114
Kela drug reimbursment
Glaucoma
43.5
323.0
1003
753
S01EE01
ATC
latanoprost; ophthalmic
27.4
323.0
676
457
S01EC01
ATC
acetazolamide; systemic
84.7
323.0
586
117
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
65.7
323.0
614
163
WX140
NOMESCO Finland
Parabulbar anesthesy
27.0
308.5
440
233
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
29.1
290.2
403
191
S01EC04
ATC
brinzolamide; ophthalmic
23.0
287.5
432
265
H20.1
ICD-10 Finland
Chronic iridocyclitis
79.5
282.9
316
51
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
24.5
265.4
389
216
CKC12
NOMESCO Finland
Photocoagulation of retina
35.6
265.0
347
128
XCW99
NOMESCO Finland
Other investigative procedure of eye
11.0
251.9
543
757
S01EA03
ATC
apraclonidine; ophthalmic
81.4
247.5
276
42
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
119.6
232.0
247
25
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
46.1
231.5
285
77
H40.0
ICD-10 Finland
Glaucoma suspect
12.7
222.6
432
474
XCK00
NOMESCO Finland
Perimetry
12.2
219.0
433
492
H43.1
ICD-10 Finland
Vitreous haemorrhage
44.0
201.9
251
69
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
5.6
198.0
881
3205
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
5.6
196.6
950
3789
XCK10
NOMESCO Finland
Photography of fundus of eye
9.5
196.4
452
667
H33.0
ICD-10 Finland
Retinal detachment with retinal break
27.7
193.9
271
120
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
10.4
186.9
403
524
S01EE03
ATC
bimatoprost; ophthalmic
23.3
175.2
258
134
Z01.0
ICD-10 Finland
Examination of eyes and vision
6.4
168.5
529
1201
S01EE05
ATC
tafluprost; ophthalmic
17.5
167.4
274
192
H34.8
ICD-10 Finland
Other retinal vascular occlusions
28.7
166.7
230
95
CKD40
NOMESCO Finland
Endophotocoagulation of retina
46.0
164.1
202
51
S01EC03
ATC
dorzolamide; ophthalmic
23.5
161.6
237
120
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
261.0
160.9
162
7
H3603, E103
ICD-10 Finland
NA
+∞
152.9
144
*
H26.2
ICD-10 Finland
Complicated cataract
51.1
151.8
183
41
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
+∞
143.2
135
*
S01EX03
ATC
NA
16.5
142.8
238
171
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
10.8
139.9
287
325
S01EC54
ATC
brinzolamide, combinations; ophthalmic
29.5
137.6
188
73
H3603, E113
ICD-10 Finland
NA
+∞
135.6
128
*
CKD20
NOMESCO Finland
Removal of vitreous body substitute
131.4
133.8
142
12
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
31.3
133.2
179
65
S01BC03
ATC
diclofenac; ophthalmic
19.5
131.5
205
122
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
278.7
126.2
127
5
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
43.0
123.5
154
40
CKC15
NOMESCO Finland
Panretinal photocoagulation
121.2
123.4
132
12
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
42.4
121.6
152
40
CJB10
NOMESCO Finland
Laser discission of secondary cataract
6.8
121.3
342
636
XCH00
NOMESCO Finland
Eye pressure measurement
11.9
118.6
229
226
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
12.7
117.4
219
201
S01EE04
ATC
travoprost; ophthalmic
15.2
117.2
201
152
CKC20
NOMESCO Finland
Cryopexy of undetached retina
145.5
114.0
120
9
H26.4
ICD-10 Finland
After-cataract
6.1
113.7
351
729
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
7.7
113.1
286
451
A10AA02
ATC
NA
15.7
109.6
185
134
CKD15
NOMESCO Finland
Injection of vitreous substitute
85.8
106.0
118
15
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
16.3
105.5
175
121
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
14.9
104.8
181
138
CKC10
NOMESCO Finland
Local photocoagulation of retina
35.7
104.8
136
42
CHF15
NOMESCO Finland
Cryotherapy of ciliary body
546.5
104.0
102
*
A10AA01
ATC
NA
24.4
100.8
145
66
H40.9
ICD-10 Finland
Glaucoma, unspecified
17.5
99.8
161
103
A10AE04
ATC
insulin glargine; parenteral
6.4
98.8
288
547
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
7.5
97.3
247
386
ZXA05
NOMESCO Finland
Left side
3.6
96.6
578
2266
S01FA04
ATC
cyclopentolate; ophthalmic
29.3
96.1
131
49
H36.01
ICD-10 Finland
Diabetic maculopathy
879.3
85.5
83
*
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
19.9
85.5
131
72
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
10.8
85.2
171
178
H25.1
ICD-10 Finland
Senile nuclear cataract
3.2
84.3
602
2633
H21.1
ICD-10 Finland
Other vascular disorders of iris and ciliary body
437.6
83.9
83
*
ZXA00
NOMESCO Finland
Right side
3.3
83.8
585
2514
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
12.6
83.1
154
136
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
16.5
81.6
134
89
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
7.1
81.4
214
347
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
16.6
80.6
132
87
T89
ICPC
Diabetes insulin dependent
13.4
76.9
138
113
H3601, E113
ICD-10 Finland
NA
398.1
76.5
76
*
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
167.1
75.8
79
5
H3601, E103
ICD-10 Finland
NA
+∞
75.7
72
*
H16.0
ICD-10 Finland
Corneal ulcer
8.2
74.1
175
240
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
10.9
73.4
146
148
A10AE05
ATC
insulin detemir; parenteral
7.4
71.5
180
272
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
7.1
70.7
183
288
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
22.1
68.5
101
49
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
13.5
68.5
122
98
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
18.3
68.0
107
63
WX100
NOMESCO Finland
Conjunctival surface anesthesia
4.1
67.8
304
892
CHB10
NOMESCO Finland
Puncture of anterior chamber of eye with irrigation
59.6
67.5
79
14
Z3229
NOMESCO Finland
Other healthcare associate professional
4.6
67.0
256
643
H40.8
ICD-10 Finland
Other glaucoma
58.8
66.5
78
14
H3600, E103
ICD-10 Finland
NA
+∞
66.2
63
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
54.9
65.8
78
15
S01ED02
ATC
betaxolol; ophthalmic
18.8
62.4
97
55
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
18.5
62.0
97
56
XCD10
NOMESCO Finland
Electrophysiological examination of eye
10.8
61.6
122
122
H21.0
ICD-10 Finland
Hyphaema
54.9
61.6
73
14
S01EB01
ATC
pilocarpine; ophthalmic
23.4
60.9
88
40
S01BC05
ATC
ketorolac; ophthalmic
6.3
59.9
170
301
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
17.9
59.4
94
56
H40.3
ICD-10 Finland
Glaucoma secondary to eye trauma
208.6
58.5
60
*
H36.00
ICD-10 Finland
Diabetic background retinopathy
95.7
58.4
64
7
103
Kela drug reimbursment
Diabetes, insulin-treated
2.8
58.2
501
2339
H3600, E113
ICD-10 Finland
NA
591.3
58.1
57
*
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
49.0
57.9
70
15
H27.0
ICD-10 Finland
Aphakia
42.1
57.8
72
18
CHC05
NOMESCO Finland
Iridotomy
12.2
56.0
104
91
CKD93
NOMESCO Finland
Extended combined procedure on vitreous body and retina
47.5
56.0
68
15
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
66.9
55.7
64
10
H04AA01
ATC
glucagon; nasal, parenteral
16.8
55.6
90
57
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
8.2
54.7
127
168
S01FA01
ATC
atropine; ophthalmic
33.4
53.5
70
22
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
20.3
52.4
79
41
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
12.3
52.0
96
83
H26.02
ICD-10 Finland
Presenil cataract
9.8
50.9
106
116
CHD65
NOMESCO Finland
Nonpenetrating glaucoma surgery
19.8
50.6
77
41
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
4.1
49.3
209
570
CHD99
NOMESCO Finland
Other filtering operation
33.4
49.0
64
20
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
8.5
48.9
111
141
H54.4
ICD-10 Finland
Blindness, monocular
71.3
48.4
55
8
H34.1
ICD-10 Finland
Central retinal artery occlusion
35.9
48.2
62
18
CKD94
NOMESCO Finland
Combined vitrectomy and procedure on lens through pars plana
17.3
48.2
77
47
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
70.0
47.4
54
8
H04.10
ICD-10 Finland
Dry eye syndrome
3.9
47.3
216
629
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.5
47.1
250
823
XCD20
NOMESCO Finland
Photoangiography of eye
13.1
46.4
83
67
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
48.5
46.4
56
12
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.6
45.8
405
1872
H40.20
ICD-10 Finland
Acute glaucoma with closed ventricular angle
31.3
45.2
60
20
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
44.8
608
3500
Z94.7
ICD-10 Finland
Corneal transplant status
43.9
44.7
55
13
WX002
NOMESCO Finland
Sedation and analgesia
2.7
44.3
374
1677
ZXA10
NOMESCO Finland
Bilateral
2.7
44.3
355
1540
WX142
NOMESCO Finland
Sub-tenon anesthesy
39.3
42.1
53
14
XCH05
NOMESCO Finland
Eye pressure longterm registration
21.6
42.1
62
30
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
9.0
42.0
91
107
H33.4
ICD-10 Finland
Traction detachment of retina
113.4
41.0
44
*
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
34.3
40.9
53
16
TCG10
NOMESCO Finland
Removal of sutures from cornea
24.7
40.4
57
24
E10
ICD-10 Finland
Type 1 diabetes mellitus
16.0
40.4
66
43
CHD00
NOMESCO Finland
Laser trabeculoplasty
12.8
39.5
71
58
H18.1
ICD-10 Finland
Bullous keratopathy
66.3
39.3
45
7
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
48.5
39.0
47
10
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
15.5
38.7
64
43
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
8.3
37.7
86
110
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
40.5
37.7
47
12
CKC60
NOMESCO Finland
Local buckling of sclera using implant
30.4
37.5
50
17
Z3231
NOMESCO Finland
Registered nurse
2.3
37.3
463
2501
CGG45
NOMESCO Finland
Full thickness transplantation of cornea using homograft
195.0
37.0
38
*
H26.3
ICD-10 Finland
Drug-induced cataract
26.4
36.9
51
20
SPAT1262
SPAT
Handing over of treatment supplies
2.6
36.5
315
1410
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
18.8
36.4
56
31
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
25.8
36.0
50
20
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
16.0
35.0
57
37
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
5.2
34.2
110
224
H40
ICD-10 Finland
Glaucoma
10.8
33.9
66
64
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.6
33.8
81
112
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
123.0
33.8
36
*
V03AE01
ATC
polystyrene sulfonate; oral
13.4
33.1
58
45
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
76.0
33.0
37
5
CKD50
NOMESCO Finland
Endodiathermy of retina
50.0
32.6
39
8
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
7.1
32.6
82
122
A10AA03
ATC
NA
16.8
32.6
52
32
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
9.5
32.6
68
75
CHD15
NOMESCO Finland
Trabeculectomy and iridectomy
15.7
32.3
53
35
CKC70
NOMESCO Finland
Circular buckling of sclera
33.2
32.3
42
13
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
11.6
32.0
60
54
H44.5
ICD-10 Finland
Degenerated conditions of globe
89.7
31.9
35
*
H57.1
ICD-10 Finland
Ocular pain
6.6
31.8
84
134
3641A
ICD-9 Finland
Disorders of iris and ciliary body, Chronic iridocyclitis
116.0
31.8
34
*
ZXE00
NOMESCO Finland
One hour or less
2.0
31.7
596
3777
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
48.7
31.7
38
8
CKC30
NOMESCO Finland
Cryopexy of detached retina
27.7
31.6
43
16
CS494
NOMESCO Finland
Other visual field testing
7.2
31.4
78
114
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
14.4
31.3
53
38
TK800
NOMESCO Finland
Hemodialysis
7.7
31.2
74
101
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.9
30.8
104
224
L04AB04
ATC
adalimumab; parenteral
8.7
30.7
67
80
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
19.8
30.6
46
24
S01FA02
ATC
scopolamine; ophthalmic
12.1
30.6
56
48
Z49.1
ICD-10 Finland
Extracorporeal dialysis
11.2
30.4
58
54
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.2
30.4
97
196
ZXD05
NOMESCO Finland
Urgent procedure
2.0
30.3
498
2981
A11CC03
ATC
alfacalcidol; systemic
7.0
30.3
76
113
A10AE06
ATC
insulin degludec; parenteral
7.9
30.0
70
93
ZXD20
NOMESCO Finland
Day surgery
2.7
29.0
224
929
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
27.8
28.1
38
14
CKD95
NOMESCO Finland
Extended combined vitectomy and lens procedure through pars plana
102.1
27.7
30
*
C03CA01
ATC
furosemide; systemic
1.9
27.6
515
3212
3656X
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA SECUNDARIA ALIA SEU NUD]
+∞
27.2
26
*
H36.02
ICD-10 Finland
Preproliferative diabetic retinopathy
+∞
27.2
26
*
TCF00
NOMESCO Finland
Subconjunctival therapeutic injection
63.3
27.0
31
5
T85.2
ICD-10 Finland
Mechanical complication of intraocular lens
22.9
26.6
38
17
C08CA01
ATC
amlodipine; oral
1.9
26.3
539
3462
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
+∞
26.1
25
*
Z94.0
ICD-10 Finland
Kidney transplant status
14.1
25.9
44
32
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
7.0
25.9
65
97
H30.2
ICD-10 Finland
Posterior cyclitis
27.6
25.8
35
13
L04AA01
ATC
[U] ciclosporin; systemic
8.4
25.8
57
70
H40.6
ICD-10 Finland
Glaucoma secondary to drugs
95.2
25.7
28
*
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
6.1
25.6
71
121
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
25.6
568
3743
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
6.3
25.5
69
114
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.9
25.5
110
301
C09AA02
ATC
enalapril; systemic
2.1
25.2
348
1914
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.4
25.2
239
1105
TCA15
NOMESCO Finland
Retrobulbar therapeutic injection into orbit
254.4
24.7
25
*
TCG00
NOMESCO Finland
Protection of cornea and sclera with soft lens
32.7
24.7
32
10
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
32.7
24.7
32
10
CKD60
NOMESCO Finland
Anterior vitrectomy
12.6
24.6
44
36
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
35.2
24.3
31
9
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
24.3
631
4360
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
29.7
24.1
32
11
H54.0
ICD-10 Finland
Blindness, binocular
57.0
24.1
28
5
H16.9
ICD-10 Finland
Keratitis, unspecified
7.7
24.0
56
75
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
23.2
24.0
34
15
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
16.2
23.7
38
24
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.2
23.7
134
453
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
11.9
23.5
43
37
A12AA04
ATC
calcium carbonate; oral
7.3
23.5
57
81
S01AX11
ATC
[U] ofloxacin; ophthalmic
3.9
23.0
97
260
H3603, E109
ICD-10 Finland
NA
+∞
23.0
22
*
H33.3
ICD-10 Finland
Retinal breaks without detachment
5.3
22.9
71
139
N18.8
ICD-10 Finland
Other chronic renal failure
5.0
22.8
75
157
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
7.1
22.6
56
82
127
Kela drug reimbursment
Transplant complication
8.3
22.5
50
62
H27.1
ICD-10 Finland
Dislocation of lens
18.3
22.2
34
19
V03AE02
ATC
sevelamer; oral
24.3
22.2
31
13
L04AA06
ATC
mycophenolic acid; systemic
7.0
22.2
55
81
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.5
22.1
185
798
CDC00
NOMESCO Finland
Enucleation of eye
+∞
21.9
21
*
36402
ICD-8 Finland
Iritis, Iridocyclitis, uveitis chronica
81.4
21.7
24
*
177
Kela drug reimbursment
Insulin glargine 300 U / ml
7.8
21.7
50
66
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.9
21.7
92
248
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
223.2
21.6
22
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
21.5
199
903
S01AD03
ATC
aciclovir; ophthalmic
4.1
21.5
86
220
B05DA
ATC
Isotonic solutions
16.5
21.5
34
21
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
21.4
827
6364
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
9.8
20.9
42
44
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
37.8
20.8
26
7
H02AB06
ATC
prednisolone; systemic
1.7
20.7
644
4630
H25.8
ICD-10 Finland
Other senile cataract
2.3
20.6
203
948
137
Kela drug reimbursment
Uraemia requiring dialysis
12.2
20.6
37
31
NHQ40
NOMESCO Finland
Amputation of toe
7.2
20.5
50
72
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.6
20.5
159
654
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
25.9
20.5
28
11
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
25.9
20.5
28
11
A07EC01
ATC
sulfasalazine; oral, rectal
2.8
20.3
135
508
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.1
20.0
113
381
3663A
ICD-9 Finland
Cataract secondary to ocular disorders
19.1
20.0
30
16
3643
FHL
Vitrectomy through pars Plana
36.3
19.9
25
7
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
15.6
19.8
32
21
C10AA01
ATC
simvastatin; oral
1.7
19.7
627
4514
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
29.4
19.7
26
9
196
Kela drug reimbursment
Paricalcitol and cinacalcet
29.4
19.7
26
9
H26.1
ICD-10 Finland
Traumatic cataract
21.9
19.5
28
13
Z49.2
ICD-10 Finland
Other dialysis
14.8
19.4
32
22
H54.1
ICD-10 Finland
Severe visual impairment, binocular
46.7
19.2
23
5
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
4.7
19.0
66
147
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
3.3
19.0
100
321
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
55.8
19.0
22
*
37520
ICD-8 Finland
Glaucoma, Secondary
34.8
18.9
24
7
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.9
18.7
343
2066
ZXC20
NOMESCO Finland
Use of chemical agents
4.7
18.7
64
141
J01FF01
ATC
clindamycin; systemic
1.8
18.6
367
2265
S01EX
ATC
Other antiglaucoma preparations
192.4
18.6
19
*
M45
ICD-10 Finland
Ankylosing spondylitis
5.5
18.6
55
103
N18.0
ICD-10 Finland
End-stage renal disease
8.5
18.5
40
48
ZX198
NOMESCO Finland
Other local administration
8.9
18.5
39
45
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
10.2
18.4
36
36
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.8
18.3
386
2437
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.8
18.3
124
472
B05DB
ATC
Hypertonic solutions
17.8
18.3
28
16
H35.6
ICD-10 Finland
Retinal haemorrhage
25.4
18.2
25
10
B03XA02
ATC
darbepoetin alfa; parenteral
5.5
18.1
54
102
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
18.1
453
3017
ZX120
NOMESCO Finland
Intravenous
2.4
18.0
162
723
H25.0
ICD-10 Finland
Senile incipient cataract
2.8
17.9
117
436
H3603, E107
ICD-10 Finland
NA
+∞
17.7
17
*
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
10.5
17.7
34
33
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
9.4
17.7
36
39
CKD99
NOMESCO Finland
Other intraoclular operations on vitreous body and retina
182.1
17.5
18
*
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
5.5
17.5
52
98
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.1
17.5
100
341
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
17.4
125
491
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
17.2
17.4
27
16
205
Kela drug reimbursment
Chronic hypertension
1.7
17.3
442
2951
SPAT1009
SPAT
Measurement of intraocular pressure
6.3
17.1
45
73
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
31.9
17.1
22
7
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
31.9
17.1
22
7
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
50.6
17.0
20
*
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
50.6
17.0
20
*
R3120
NOMESCO Finland
Training in mobility skills
50.6
17.0
20
*
CJF30
NOMESCO Finland
Reduction of dislocation of artificial lens
22.2
16.9
24
11
T90
ICPC
Diabetes non-insulin dependent
1.9
16.9
306
1829
H20.8
ICD-10 Finland
Other iridocyclitis
14.3
16.8
28
20
S97
ICPC
Chronic ulcer skin
3.0
16.8
101
356
3793A
ICD-9 Finland
Other disorders of eye, Aphakia and other disorders of lens[APHAKIA]
64.1
16.8
19
*
3656F
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA POST UVEITIDEM]
+∞
16.7
16
*
H3602, E103
ICD-10 Finland
NA
+∞
16.7
16
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
16.6
194
979
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
16.5
363
2308
H33.5
ICD-10 Finland
Other retinal detachments
10.9
16.5
31
29
3610A
ICD-9 Finland
Retinal detachments and defects, Retinal detachment with retinal defect
20.3
16.4
24
12
CFD10
NOMESCO Finland
Repair of conjunctiva
30.4
16.1
21
7
H33.2
ICD-10 Finland
Serous retinal detachment
30.4
16.1
21
7
C02AC05
ATC
moxonidine; oral
3.3
16.1
84
269
H18.8
ICD-10 Finland
Other specified disorders of cornea
11.8
16.1
29
25
Z49.0
ICD-10 Finland
Preparatory care for dialysis
8.7
16.0
34
40
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
15.9
300
1810
A10BB01
ATC
glibenclamide; oral
3.0
15.8
95
333
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
11.4
15.8
29
26
3626
FHL
Extracapsular cataract surgery and implantation of an artificial lens
4.5
15.7
55
125
H34.2
ICD-10 Finland
Other retinal artery occlusions
17.4
15.6
24
14
H25.2
ICD-10 Finland
Senile cataract, morgagnian type
11.9
15.6
28
24
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
13.9
15.5
26
19
3711
FHL
Cyclodiateria or cryocoagulation
161.7
15.5
16
*
H40.22
ICD-10 Finland
Chronic glaucoma with closed ventricular angle
7.5
15.5
36
49
S01EA02
ATC
dipivefrine; ophthalmic
10.2
15.5
30
30
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
3.8
15.4
66
181
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
15.3
215
1167
XCW10
NOMESCO Finland
Assessment of vision
16.2
15.3
24
15
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
10.5
15.2
29
28
V03AE03
ATC
lanthanum carbonate; oral
28.9
15.2
20
7
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
18.0
15.2
23
13
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
18.0
15.2
23
13
2504B
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]
45.5
15.1
18
*
CG2T4
NOMESCO Finland
Topography assessment of cornea
9.3
14.7
30
33
CS2P4
NOMESCO Finland
Optic nerve head imaging
13.4
14.7
25
19
H43.8
ICD-10 Finland
Other disorders of vitreous body
2.5
14.7
119
502
CJF00
NOMESCO Finland
Secondary implantation of artificial lens in anterior chamber
25.3
14.7
20
8
3620B
ICD-9 Finland
Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]
+∞
14.6
14
*
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
80.9
14.6
16
*
H34.9
ICD-10 Finland
Retinal vascular occlusion, unspecified
80.9
14.6
16
*
CKD45
NOMESCO Finland
Endocryotherapy of retina
151.5
14.5
15
*
F29
ICPC
Eye symptom/complaint other
2.5
14.5
115
481
S01FA06
ATC
tropicamide; ophthalmic
36.4
14.5
18
5
AA1AD
NOMESCO Finland
CT of head and brain
1.7
14.4
342
2214
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
19.3
14.2
21
11
H18.2
ICD-10 Finland
Other corneal oedema
22.5
14.2
20
9
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
14.2
233
1337
CA1ME
NOMESCO Finland
Ultrasound oculometry
8.5
14.0
30
36
SPAT1229
SPAT
Assessment of need for aid
2.3
13.9
137
637
3708
FHL
Trabeculectomy or equivalent
24.0
13.8
19
8
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
13.7
538
3974
ZYC01
NOMESCO Finland
Remote contact by phone
3.2
13.6
72
234
H18.6
ICD-10 Finland
Keratoconus
14.9
13.6
22
15
3649
FHL
Other measure in this category
+∞
13.6
13
*
E10.01
ICD-10 Finland
Insulin-dependent diabetes diabetic coma with hyperglycemia
+∞
13.6
13
*
H3602, E113
ICD-10 Finland
NA
+∞
13.6
13
*
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.4
13.5
65
197
H40.19
ICD-10 Finland
Other primary glaucoma with open ventricular angle
13.0
13.4
23
18
B01AC04
ATC
clopidogrel; oral
1.8
13.4
237
1397
L04AA17
ATC
[U] adalimumab; parenteral
18.4
13.4
20
11
CJF15
NOMESCO Finland
Secondary implantation of skleral fixed artificial lens in posterior chamber
26.0
13.4
18
7
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
13.4
292
1838
S18
ICPC
Laceration/cut
1.6
13.4
525
3876
TK820
NOMESCO Finland
Peritoneal dialysis
21.4
13.3
19
9
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
21.4
13.3
19
9
S05.1
ICD-10 Finland
Contusion of eyeball and orbital tissues
5.2
13.2
40
78
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
13.1
404
2803
CFW99
NOMESCO Finland
Other operation on conjunctiva
15.2
13.1
21
14
A28
ICPC
Limited function/disability NOS
1.8
13.1
239
1423
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
2.7
13.0
92
360
25008
ICD-8 Finland
Diabetes mellitus, Complicatio alia definita
28.6
13.0
17
6
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.7
12.9
346
2311
L04AX01
ATC
azathioprine; systemic
3.1
12.9
71
238
S05.6
ICD-10 Finland
Penetrating wound of eyeball without foreign body
50.5
12.9
15
*
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
9.1
12.7
26
29
H15.1
ICD-10 Finland
Episcleritis
5.7
12.7
36
65
Z2221
NOMESCO Finland
Medical doctor
1.6
12.7
370
2526
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
15.6
12.6
20
13
36400
ICD-8 Finland
Iritis, Iridocyclitis acuta
12.4
12.6
22
18
I79.2*E10.5
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
70.5
12.6
14
*
H221, M084
ICD-10 Finland
NA
+∞
12.5
12
*
N083, E102
ICD-10 Finland
NA
+∞
12.5
12
*
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
8.8
12.5
26
30
A10AB06
ATC
insulin glulisine; parenteral
9.4
12.5
25
27
H22.1
ICD-10 Finland
Iridocyclitis in other diseases classified elsewhere
131.1
12.5
13
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.6
12.4
92
369
L04AA13
ATC
leflunomide; oral
4.2
12.4
46
112
F93
ICPC
Glaucoma
11.7
12.3
22
19
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.3
12.2
116
530
S05.0
ICD-10 Finland
Injury of conjunctiva and corneal abrasion without mention of foreign body
4.7
12.0
40
87
25002
ICD-8 Finland
Diabetes mellitus, Retinopathia diabetica
47.1
11.9
14
*
CJF20
NOMESCO Finland
Removal of artificial lens
47.1
11.9
14
*
H44.0
ICD-10 Finland
Purulent endophthalmitis
47.1
11.9
14
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
11.9
242
1489
CKW99
NOMESCO Finland
Other operation on choroid, vitreous body and retina
11.8
11.8
21
18
H54.7
ICD-10 Finland
Unspecified visual loss
8.5
11.8
25
30
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
8.5
11.8
25
30
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
14.8
11.8
19
13
L88
ICPC
Rheumatoid/seropositive arthritis
3.2
11.8
61
196
CHD35
NOMESCO Finland
Laser goniopuncture
10.6
11.8
22
21
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
11.7
232
1416
2507B
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]
30.3
11.6
15
5
H02.4
ICD-10 Finland
Ptosis of eyelid
3.7
11.6
50
139
CJF10
NOMESCO Finland
Secondary implantation of artificial lens in posterior chamber
65.5
11.6
13
*
CJF45
NOMESCO Finland
Removal and implantation of artificial lens in anterior chamber with iridectomy or iridotomy
19.1
11.6
17
9
S01BA09
ATC
clobetasone; ophthalmic
19.1
11.6
17
9
3640A
ICD-9 Finland
Disorders of iris and ciliary body, Acute and subacute iridocyclitis
19.1
11.6
17
9
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
5.0
11.6
36
73
A02BC02
ATC
pantoprazole; systemic
1.5
11.6
821
6827
37403
ICD-8 Finland
Cataract, Complicata
23.1
11.6
16
7
H05BX01
ATC
cinacalcet; oral
11.2
11.5
21
19
A10BA02
ATC
metformin; oral
1.6
11.5
360
2492
CL2L4
NOMESCO Finland
Wide-field fundus photography for diabetic retinopathy screening
+∞
11.5
11
*
3718X
ICD-9 Finland
Corneal opacity and other disorders of cornea, Other corneal disorders
+∞
11.5
11
*
M14.6
ICD-10 Finland
Neuropathic arthropathy
+∞
11.5
11
*
CHC00
NOMESCO Finland
Iridotomy
120.9
11.4
12
*
CGG60
NOMESCO Finland
Reinforcement of sclera using graft
120.9
11.4
12
*
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
120.9
11.4
12
*
H35.29
ICD-10 Finland
Other proliferative retinopathy
120.9
11.4
12
*
CG2S4
NOMESCO Finland
Photography of cornea
11.9
11.3
20
17
CHB15
NOMESCO Finland
Puncture of anterior chamber of eye with replacement of aqueous
35.3
11.3
14
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.5
11.3
86
353
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.8
11.3
70
254
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.6
11.2
50
144
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
11.1
193
1126
L04AD01
ATC
ciclosporin; systemic
4.3
11.1
40
95
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
11.1
102
462
N02BE01
ATC
paracetamol; systemic, rectal
1.6
11.0
1112
9926
F01
ICPC
Eye pain
3.9
11.0
44
115
CHB99
NOMESCO Finland
Other operation on anterior chamber and anterior chamber angle
43.7
10.9
13
*
3792A
ICD-9 Finland
Other disorders of eye, Disorders of vitreous body
43.7
10.9
13
*
H01.0
ICD-10 Finland
Blepharitis
2.7
10.8
75
289
37872
ICD-8 Finland
Other diseases of eye, Aphakia artefacta, acquisita
15.6
10.8
17
11
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
10.8
232
1446
C08CA13
ATC
lercanidipine; oral
1.8
10.7
182
1053
B03XA01
ATC
erythropoietin; parenteral
6.4
10.6
27
43
CGG99
NOMESCO Finland
Other reconstructive operations on cornea and sclera
60.4
10.6
12
*
3719
FHL
Other measure in this category
60.4
10.6
12
*
H40.11
ICD-10 Finland
Low pressure glaucoma
3.8
10.6
44
119
A10BB12
ATC
glimepiride; oral
2.2
10.6
113
546
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
10.6
130
666
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
3.3
10.6
53
167
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
4.9
10.5
33
68
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
9.2
10.5
21
23
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
9.2
10.5
21
23
H44.4
ICD-10 Finland
Hypotony of eye
110.8
10.4
11
*
36409
ICD-8 Finland
Iritis, Unspecified
110.8
10.4
11
*
Q15.0
ICD-10 Finland
Congenital glaucoma
110.8
10.4
11
*
H22.1*D86.8
ICD-10 Finland
Iridocyclitis in sarcoidosis
110.8
10.4
11
*
N0830, E102
ICD-10 Finland
NA
110.8
10.4
11
*
RJ120
NOMESCO Finland
NA
110.8
10.4
11
*
3747
FHL
Combined ablation and vitreous surgery with coagulation
+∞
10.4
10
*
JLE03
NOMESCO Finland
Allogenic total transplantation of pancreas with pancreaticoenterostomy
+∞
10.4
10
*
CWW99
NOMESCO Finland
Other reoperation on eye and adjacent structures
+∞
10.4
10
*
T85.3
ICD-10 Finland
Mechanical complication of other ocular prosthetic devices, implants and grafts
+∞
10.4
10
*
C10AA05
ATC
atorvastatin; oral
1.5
10.4
484
3658
SPAT1263
SPAT
Sampling
1.5
10.4
526
4046
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
16.2
10.4
16
10
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
6.4
10.3
26
41
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.7
10.3
68
255
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
2.4
10.3
83
352
Z2446
NOMESCO Finland
Social worker
2.2
10.3
99
458
L04AA11
ATC
[U] etanercept; parenteral
18.9
10.3
15
8
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
18.9
10.3
15
8
J01DB01
ATC
cefalexin; oral
1.5
10.3
1034
9128
4AA12
NOMESCO Finland
NA
23.5
10.2
14
6
S01KA02
ATC
hypromellose; ophthalmic
4.2
10.2
37
89
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
10.2
191
1140
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
10.1
10.0
19
19
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.9
10.0
60
215
71200
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis
40.3
10.0
12
*
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
40.3
10.0
12
*
CGF10
NOMESCO Finland
Suture of laceration of cornea
40.3
10.0
12
*
CKC65
NOMESCO Finland
Removal of buckling implant from sclera
40.3
10.0
12
*
CHW99
NOMESCO Finland
Other operation on anterior chamber, anterior chamber angle, iris or ciliary body
40.3
10.0
12
*
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.7
9.9
42
116
C07AB07
ATC
bisoprolol; oral
1.4
9.8
619
4962
NGQ20
NOMESCO Finland
Amputation of lower leg
8.2
9.8
21
26
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
9.8
322
2245
WX110
NOMESCO Finland
Local anesthesy
1.4
9.8
808
6815
SPAT1301
SPAT
No procedures
1.5
9.8
402
2950
I50.0
ICD-10 Finland
Congestive heart failure
2.0
9.7
128
676
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.2
9.7
29
57
3651A
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]
7.4
9.7
22
30
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
13.5
9.7
16
12
8720/3-C69.3
ICD-O-3
Malignant melanoma, NOS, of choroid
55.4
9.7
11
*
CK9F4
NOMESCO Finland
Fluorescein angiography (FAG) of choroid and retina
9.2
9.5
19
21
H28.0
ICD-10 Finland
Diabetic cataract
100.7
9.4
10
*
CDC40
NOMESCO Finland
Evisceration of eye with insertion of prosthesis
100.7
9.4
10
*
TCH12
NOMESCO Finland
Sample aspiration from anterior chambre
100.7
9.4
10
*
Z97.0
ICD-10 Finland
Presence of artificial eye
100.7
9.4
10
*
H3603, H405
ICD-10 Finland
NA
+∞
9.4
9
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.6
9.4
40
112
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
21.8
9.4
13
6
L28
ICPC
Limited function/disability (L)
1.7
9.3
223
1431
Z5132
NOMESCO Finland
Nursing associate professional
10.7
9.3
17
16
H18.4
ICD-10 Finland
Corneal degeneration
9.6
9.3
18
19
R06.0
ICD-10 Finland
Dyspnoea
1.5
9.2
310
2171
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.9
9.1
36
94
H40.12
ICD-10 Finland
Pigmentary glaucoma
11.5
9.1
16
14
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.0
9.1
35
90
CFB00
NOMESCO Finland
Suture of conjunctiva
15.7
9.0
14
9
M65.3
ICD-10 Finland
Trigger finger
2.9
9.0
53
188
CHD10
NOMESCO Finland
Trabeculectomy
24.2
8.9
12
5
A46
ICD-10 Finland
Erysipelas
1.7
8.9
183
1126
N03AX16
ATC
pregabalin; oral
1.6
8.8
273
1873
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
2.4
8.8
70
295
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
8.8
130
716
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
8.7
398
2976
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
8.7
359
2626
H17.8
ICD-10 Finland
Other corneal scars and opacities
14.1
8.7
14
10
74439
ICD-8 Finland
Congenital anomalies of eye, Cataracta NUD
50.3
8.7
10
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
8.7
460
3541
RS221
NOMESCO Finland
NA
5.1
8.7
26
52
ZZA00
NOMESCO Finland
Split skin graft
2.9
8.6
50
175
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.4
8.6
45
992
F28
ICPC
Limited function/disability (F)
6.2
8.6
22
36
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
5.5
8.6
24
44
S01FB01
ATC
phenylephrine; ophthalmic (sympathomimetics excl. antiglaucoma prep.)
27.7
8.5
11
*
S01GX01
ATC
cromoglicic acid; ophthalmic
1.6
8.4
208
1343
3604
FHL
Penetration of the cornea
90.6
8.4
9
*
H221, M083
ICD-10 Finland
NA
90.6
8.4
9
*
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
4.9
8.4
26
54
N08.32
ICD-10 Finland
Glomerular disorders in diabetes mellitus kidney failure
+∞
8.3
8
*
H3603, H431
ICD-10 Finland
NA
+∞
8.3
8
*
R4180
NOMESCO Finland
Podiatric therapy
6.3
8.3
21
34
H18.5
ICD-10 Finland
Hereditary corneal dystrophies
5.9
8.3
22
38
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.0
8.3
47
161
PE1AT
NOMESCO Finland
Femoral artery PTA
4.8
8.3
26
55
A41.9
ICD-10 Finland
Sepsis, unspecified
2.6
8.2
60
241
R4110
NOMESCO Finland
Physiotherapy
1.5
8.2
323
2337
WX213
NOMESCO Finland
Lower leg blockade
7.6
8.2
18
24
L84
ICD-10 Finland
Corns and callosities
2.7
8.1
52
195
H17.1
ICD-10 Finland
Other central corneal opacity
33.5
8.1
10
*
H16.1
ICD-10 Finland
Other superficial keratitis without conjunctivitis
11.8
8.1
14
12
H35.36
ICD-10 Finland
Macular cyst
6.9
8.1
19
28
F99
ICPC
Eye/adnexa disease other
6.9
8.1
19
28
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.9
8.1
31
80
C10AX09
ATC
ezetimibe; oral
1.9
8.0
126
709
CF2S4
NOMESCO Finland
Photography of conjunctiva
22.1
8.0
11
5
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
4.1
8.0
29
71
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
5.6
8.0
22
40
SPAT1310
SPAT
Counselling related to known health issue
1.5
8.0
364
2715
H54.5
ICD-10 Finland
Severe visual impairment, monocular
7.8
7.9
17
22
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.5
7.8
60
247
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.6
7.8
55
219
R11
ICD-10 Finland
Nausea and vomiting
1.9
7.7
103
548
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
6.4
7.7
19
30
CKA10
NOMESCO Finland
Biopsy of vitreous body
15.1
7.7
12
8
M86.6
ICD-10 Finland
Other chronic osteomyelitis
15.1
7.7
12
8
S05.2
ICD-10 Finland
Ocular laceration and rupture with prolapse or loss of intraocular tissue
45.2
7.7
9
*
CK2K4
NOMESCO Finland
Red-free imaging of ocular fundus
45.2
7.7
9
*
PD4CC
NOMESCO Finland
Very extensive arterigography of lower extremity with X-ray
7.5
7.7
17
23
RD210
NOMESCO Finland
NA
3.9
7.7
30
79
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
7.6
98
513
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.1
7.6
83
407
CH2S4
NOMESCO Finland
Photography of iris
18.5
7.6
11
6
Q12.0
ICD-10 Finland
Congenital cataract
18.5
7.6
11
6
CK2M4
NOMESCO Finland
Macular light layer imaging (OCT)
18.5
7.6
11
6
QDA10
NOMESCO Finland
Incision of skin of lower limb
8.1
7.6
16
20
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
7.6
343
2548
CJE15
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in anterior chamber and iridectomy or iridotomy
5.0
7.6
23
47
C09CA01
ATC
losartan; oral
1.5
7.6
298
2150
M14.6*A52.1
ICD-10 Finland
Charcot's or tabetic arthropathy
25.1
7.6
10
*
B00.5
ICD-10 Finland
Herpesviral ocular disease
25.1
7.6
10
*
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
2.4
7.6
63
274
A10AD04
ATC
insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
10.1
7.5
14
14
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.4
7.5
59
248
C09BA02
ATC
enalapril and diuretics; systemic
1.9
7.5
118
663
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.8
7.5
125
721
H21.9
ICD-10 Finland
Disorder of iris and ciliary body, unspecified
80.5
7.4
8
*
C69.39
ICD-10 Finland
Malignant tumor in chorioidea other or unspecified histology
80.5
7.4
8
*
L04AB06
ATC
golimumab; parenteral
7.7
7.4
16
21
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
7.4
320
2355
H43.3
ICD-10 Finland
Other vitreous opacities
4.8
7.3
23
49
SPAT1254
SPAT
Administration of medicine
1.6
7.3
197
1303
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.1
7.3
76
366
3619
FHL
Other operations in this group, such as corneal refractive surgery
+∞
7.3
7
*
C69.42
ICD-10 Finland
Malignant tumor of ciliary melanoma
+∞
7.3
7
*
ZZL00
NOMESCO Finland
Free graft of amniotic membrane
+∞
7.3
7
*
CKD30
NOMESCO Finland
Internal drainage of subretinal fluid
+∞
7.3
7
*
3656E
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA POSTTRAUMATICUM]
+∞
7.3
7
*
CJB99
NOMESCO Finland
Other operation on lens for secondary cataract
+∞
7.3
7
*
7433A
ICD-9 Finland
Congenital anomalies of eye, Congenital cataract and lens anomalies
+∞
7.3
7
*
H360, E103
ICD-10 Finland
NA
+∞
7.3
7
*
3624
FHL
Extracapsular soft cataract removal
+∞
7.3
7
*
H16.3
ICD-10 Finland
Interstitial and deep keratitis
+∞
7.3
7
*
H3603, E119
ICD-10 Finland
NA
+∞
7.3
7
*
RJ410
NOMESCO Finland
NA
9.4
7.3
14
15
SPAT1216
SPAT
Assessment of functional ability
1.6
7.2
209
1403
S01BC01
ATC
indometacin; ophthalmic
15.8
7.2
11
7
XCD00
NOMESCO Finland
Clinical examination of eye in general anaesthesia
30.2
7.1
9
*
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.5
7.1
53
216
H44.2
ICD-10 Finland
Degenerative myopia
20.1
7.1
10
5
NDG30
NOMESCO Finland
Fusion of wrist, total
8.0
7.1
15
19
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.9
7.1
41
144
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.6
7.1
50
199
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
7.1
375
2867
160
Kela drug reimbursment
exenatide
3.9
7.1
27
70
P01BA02
ATC
hydroxychloroquine; oral
1.9
7.1
94
501
N03AX12
ATC
gabapentin; oral
1.6
7.1
175
1131
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
7.1
107
596
I79.2*E11.5
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
10.1
7.0
13
13
RJ420
NOMESCO Finland
NA
10.1
7.0
13
13
E0000UV
ATC
NA
1.4
7.0
457
3621
N19
ICD-10 Finland
Unspecified kidney failure
2.5
7.0
53
220
J01CF05
ATC
flucloxacillin; systemic
2.5
7.0
53
220
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
7.0
7.0
16
23
W44
ICD-10 Finland
Foreign body entering into or through eye or natural orifice
3.9
7.0
27
71
A10BH05
ATC
linagliptin; oral
2.2
6.9
67
314
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
7.6
6.9
15
20
3744
FHL
Pericardial identification surgery with coagulation (includes epi- and intrascleral indications and eg Lincoff catheter)
13.8
6.9
11
8
H15.0
ICD-10 Finland
Scleritis
13.8
6.9
11
8
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
13.8
6.9
11
8
RJ521
NOMESCO Finland
NA
13.8
6.9
11
8
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
6.9
130
779
C09AA05
ATC
ramipril; oral
1.4
6.8
318
2371
CD2S4
NOMESCO Finland
Photography of eye
6.7
6.8
16
24
TK810
NOMESCO Finland
Hemofiltration
6.7
6.8
16
24
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.0
6.8
84
436
F43
ICPC
Eye, Other diagnostic procedure
3.7
6.8
27
73
CJE00
NOMESCO Finland
Phakoemulsification
40.2
6.8
8
*
Z96.4
ICD-10 Finland
Presence of endocrine implants
40.2
6.8
8
*
CGF45
NOMESCO Finland
Suture of laceration of sclera
40.2
6.8
8
*
C69.3
ICD-10 Finland
Malignant neoplasm: Choroid
16.8
6.7
10
6
H16.2
ICD-10 Finland
Keratoconjunctivitis
7.2
6.7
15
21
H40.29
ICD-10 Finland
Other [primary] glaucoma with closed ventricular angle
22.6
6.7
9
*
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
22.6
6.7
9
*
RJ210
NOMESCO Finland
NA
22.6
6.7
9
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
6.6
276
2011
R42
ICD-10 Finland
Dizziness and giddiness
1.5
6.6
272
1976
H53.1
ICD-10 Finland
Subjective visual disturbances
2.1
6.6
73
359
H19.1
ICD-10 Finland
Herpesviral keratitis and keratoconjunctivitis
12.3
6.6
11
9
G63.2
ICD-10 Finland
Diabetic polyneuropathy
8.7
6.6
13
15
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
8.7
6.6
13
15
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
10.1
6.5
12
12
I25.2
ICD-10 Finland
Old myocardial infarction
1.8
6.5
115
674
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.5
439
3494
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
6.5
26
71
M01CB01
ATC
sodium aurothiomalate; parenteral
3.7
6.5
26
71
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
3.4
6.4
29
87
J01DA01
ATC
[U] cefalexin; systemic
1.3
6.4
769
6684
H20.2
ICD-10 Finland
Lens-induced iridocyclitis
70.1
6.4
7
*
CAW99
NOMESCO Finland
Other operation on orbit
70.1
6.4
7
*
37100
ICD-8 Finland
Corneal opacity, Cicatrix (nubecula, macula, leucoma) cornea
70.1
6.4
7
*
H360, E113
ICD-10 Finland
NA
70.1
6.4
7
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.9
6.4
91
498
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
3.0
6.4
34
115
CBJ30
NOMESCO Finland
Plastic repair of levator aponeurosis of eyelid
7.4
6.4
14
19
SPAT1325
SPAT
Vaccination
1.4
6.4
419
3314
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
4.1
6.4
23
57
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.0
6.4
74
374
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.9
6.4
92
503
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
6.4
119
712
S20
ICPC
Corn/callosity
3.2
6.4
31
99
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.1
6.3
71
352
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.3
6.3
57
259
N02AA05
ATC
oxycodone; systemic
1.5
6.3
192
1308
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
4.0
6.3
23
58
3650A
ICD-9 Finland
Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AVOKULMA)]
9.3
6.3
12
13
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
4.6
6.3
20
44
CA1AD
NOMESCO Finland
Orbita CT
18.1
6.3
9
5
RJ414
NOMESCO Finland
NA
18.1
6.3
9
5
C69.40
ICD-10 Finland
Malignant tumor of ciliary body without histology
+∞
6.3
6
*
3702
FHL
Trabeculotomy
+∞
6.3
6
*
H3603, E117
ICD-10 Finland
NA
+∞
6.3
6
*
3768
FHL
Eye examination under general anesthesia
+∞
6.3
6
*
CWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in eye and adjacent structures
+∞
6.3
6
*
H36.04
ICD-10 Finland
Severe diabetic ophthalmopathy
+∞
6.3
6
*
36401
ICD-8 Finland
Iritis, Iridocyclitis glaucomatosa. Syndroma Posner-Schlossman, heterochromia iridis
+∞
6.3
6
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.6
6.2
150
964
CGF35
NOMESCO Finland
Repair of cornea using graft
26.8
6.2
8
*
J01MA02
ATC
ciprofloxacin; systemic
1.3
6.2
484
3934
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.9
6.2
34
118
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
6.2
244
1756
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.6
6.2
154
1000
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
6.3
6.2
15
24
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.1
6.1
66
325
UJF32
NOMESCO Finland
Coloscopy
1.4
6.1
304
2289
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
3.2
6.1
29
91
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.9
6.1
80
424
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.7
6.1
110
652
CJ2M4
NOMESCO Finland
Scans and measurement printouts for intraocular lens power calculation
4.0
6.1
22
55
CJD20
NOMESCO Finland
Extracapsular cataract extraction with implantation of artificial lens in posterior chamber
10.1
6.0
11
11
TQW80
NOMESCO Finland
Local dermatologic skincare
2.7
6.0
37
138
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.8
6.0
36
132
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
324
1416
2.63
47.21
2.5
1.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
250
1110
2.49
34.44
16.0
6.9
mmol/l
13.3
10.5
6.44
240
1047
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
222
936
2.60
34.07
7.0
3.7
ng/l
139.9
90.3
4.44
194
805
(3003458) Phosphate [Moles/volume] in Serum or Plasma
329
1656
2.25
34.01
13.3
5.3
mmol/l
1.2
1.0
8.85
308
1516
(3013115) Eosinophils [#/volume] in Blood
842
6029
1.87
31.24
9.2
5.9
e9/l
0.2
0.2
0.60
767
5263
(3006315) Basophils [#/volume] in Blood
819
5828
1.86
30.85
9.1
5.6
e9/l
0.0
0.0
0.69
751
5004
(3012516) Albumin [Mass/volume] in Urine
536
3355
1.91
30.05
4.9
3.1
mg/l
509.6
300.0
0.53
392
2140
(3001604) Monocytes [#/volume] in Blood
813
5804
1.84
29.99
9.1
5.6
e9/l
0.6
0.6
0.85
745
4969
(3019198) Lymphocytes [#/volume] in Blood
830
5969
1.84
29.84
9.1
5.7
e9/l
1.7
1.9
3.03
759
5208
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
25
15
16.92
29.82
6.4
4.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
558
3569
1.88
29.05
5.9
3.7
mg/mmol
25.3
8.1
4.24
412
2262
(3042733) HLA Ab [Presence] in Serum
29
25
11.80
28.32
5.8
4.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
747
5309
1.78
26.94
6.9
4.7
g/l
33.9
35.1
6.30
702
4909
(3014148) Varicella zoster virus Ab [Titer] in Serum
54
105
5.29
26.57
1.2
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
546
3555
1.83
26.27
4.8
3.0
mmol/l
6.5
7.6
9.12
468
2949
(40768446) Kidney Pathology biopsy report
31
33
9.56
26.24
1.9
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
319
1763
2.02
25.12
3.1
2.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
87
259
3.50
24.60
3.1
2.3
ug/min
145.1
91.0
0.71
51
161
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
126
473
2.81
24.06
3.0
2.0
u/l
41.9
38.6
0.84
113
420
(3013650) Neutrophils [#/volume] in Blood by Automated count
891
6792
1.73
24.02
11.3
8.7
e9/l
4.5
4.2
2.33
811
5901
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
27
27
10.16
23.87
2.1
2.0
mg/l
9.9
10.3
0.08
18
21
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
26
25
10.56
23.60
1.1
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
25
23
11.03
23.37
1.1
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
54
121
4.59
22.54
1.2
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
403
2492
1.83
22.30
6.1
4.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
729
5339
1.69
22.09
9.3
5.8
%
0.6
0.7
0.14
694
4956
(3019069) Monocytes/100 leukocytes in Blood
747
5518
1.68
21.82
9.5
6.1
%
8.7
8.8
0.05
711
5140
(3006504) Eosinophils/100 leukocytes in Blood
744
5494
1.68
21.73
9.3
5.8
%
2.8
2.8
0.09
707
5091
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
91
302
3.14
21.62
2.6
2.1
mg/l
11.7
11.6
0.03
91
274
(3035350) Ketones [Presence] in Urine by Test strip
772
5783
1.67
21.13
5.2
3.8
estimate
0.0
0.0
0.00
172
1108
(3002030) Lymphocytes/100 leukocytes in Blood
758
5658
1.66
20.98
9.3
5.9
%
25.4
27.0
3.88
720
5248
(42870588) Differential panel, method unspecified - Blood
575
4009
1.69
20.58
9.1
5.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
801
6102
1.65
20.17
12.6
6.6
mmol/l
1.2
1.2
1.69
673
5124
(3018010) Neutrophils/100 leukocytes in Blood
743
5559
1.64
20.07
9.0
5.7
%
59.9
57.9
4.72
707
5180
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1108
9184
1.72
20.02
10.1
7.4
u/l
81.1
79.3
0.73
1053
8599
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
294
1697
1.90
19.98
5.3
2.5
%
20.8
22.6
1.90
263
1440
(3012095) Magnesium [Moles/volume] in Serum or Plasma
329
1969
1.85
19.97
3.6
3.3
mmol/l
0.8
0.8
0.06
308
1839
(3004789) Transferrin [Mass/volume] in Serum or Plasma
310
1824
1.87
19.84
5.0
2.4
g/l
2.1
2.3
4.40
297
1677
(3009261) Glucose [Presence] in Urine by Test strip
770
5841
1.63
19.47
5.3
3.8
estimate
0.0
0.0
0.35
158
1096
(3017143) Hepatitis C virus Ab [Presence] in Serum
217
1137
2.06
19.46
2.6
1.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
18
13
14.00
19.37
9.7
16.8
mmol/l
6.0
6.2
0.04
18
13
(3021447) Carbon dioxide [Partial pressure] in Venous blood
224
1193
2.03
19.19
8.0
3.6
kpa
5.9
5.8
0.91
217
1160
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
71
218
3.36
19.15
2.1
1.4
—
19.9
—
0
5
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
71
218
3.36
19.15
2.2
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
473
3179
1.70
19.12
5.8
4.1
estimate
0.0
0.0
1.08
149
1075
(3021601) Nitrite [Presence] in Urine by Test strip
761
5777
1.62
19.02
6.8
5.2
estimate
0.0
0.0
0.50
173
1115
(3022948) Iron [Moles/volume] in Serum or Plasma
326
1977
1.82
18.84
5.0
2.4
umol/l
11.0
12.7
5.34
312
1820
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
255
1431
1.94
18.78
3.8
4.0
u/l
250.6
248.9
0.06
246
1346
(3002032) Base excess in Venous blood by calculation
222
1188
2.01
18.75
9.4
3.6
mmol/l
1.2
2.0
3.33
186
945
(3024471) HLA-A [Type]
24
29
8.39
18.41
1.0
1.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
134
591
2.39
18.34
2.1
1.8
g/l
1.6
1.5
0.26
115
512
(3021589) Normoblasts [#/volume] in Blood
690
5168
1.60
17.86
15.7
9.7
e9/l
0.0
0.0
0.11
607
4214
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
64
193
3.42
17.77
2.2
1.4
u/ml
113.8
129.2
0.29
17
37
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
730
5548
1.60
17.72
11.9
5.8
mmol/l
1.2
1.2
0.46
667
5001
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72
235
3.16
17.60
9.3
5.4
iu/ml
883.5
503.3
0.25
17
33
(3000850) Epithelial cells [#/volume] in Urine
408
2689
1.70
17.48
3.8
2.6
e6/l
5.4
5.3
0.03
363
2376
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
86
313
2.85
17.38
5.0
4.0
mg/l
1.9
1.6
2.17
80
284
(3018418) pH of Serum or Plasma
514
3604
1.64
17.31
9.5
3.8
ph
7.4
7.4
1.75
109
684
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
44
104
4.32
17.21
1.2
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
192
1005
2.04
17.18
6.3
3.0
kpa
4.6
4.6
0.21
185
976
(3025159) Blasts/100 leukocytes in Blood
173
873
2.10
17.07
4.4
4.3
%
0.7
0.5
0.13
46
241
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
655
4883
1.59
17.05
4.9
3.9
ng/l
139.0
51.9
0.45
502
3527
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
471
3256
1.64
16.67
2.8
2.2
mg/l
3.3
3.0
1.24
421
2746
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
636
4730
1.58
16.60
2.9
2.2
nmol/l
75.3
77.8
1.56
573
4184
(3013707) Erythrocyte sedimentation rate by Westergren method
1040
8676
1.60
16.32
5.6
4.0
mm/h
16.3
13.0
7.46
965
7957
(3014576) Chloride [Moles/volume] in Serum or Plasma
263
1555
1.83
16.32
8.9
6.9
mmol/l
103.5
104.4
2.09
253
1516
(3032080) INR in Blood by Coagulation assay
680
5155
1.57
16.21
11.8
10.3
inr
1.2
1.3
1.19
214
1461
(3013826) Glucose [Moles/volume] in Serum or Plasma
890
7172
1.56
16.15
8.7
4.7
mmol/l
7.6
6.7
19.67
855
6719
(3002179) Metamyelocytes/100 leukocytes in Blood
172
884
2.06
16.14
4.0
4.1
%
0.4
0.6
0.52
39
225
(3023368) Bacteria identified in Blood by Culture
509
3613
1.61
16.06
6.3
4.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
44
111
4.05
15.82
2.4
2.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
177
927
2.03
15.77
4.3
4.3
%
0.1
0.1
0.03
51
284
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
605
4498
1.57
15.53
5.5
4.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
254
1510
1.82
15.42
3.4
2.4
%
1.9
1.8
0.82
237
1327
(3026008) Bacteria identified in Urine by Culture
529
3825
1.58
15.27
3.7
3.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
66
223
3.05
15.24
3.8
3.2
e9/l
4.7
4.4
0.26
66
223
(3017181) Myelocytes/100 leukocytes in Blood
183
982
1.98
15.21
4.3
4.2
%
0.6
0.9
0.96
54
311
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
516
3714
1.58
15.17
3.3
3.2
u/l
34.3
33.8
0.04
489
3526
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
227
1312
1.86
15.08
3.8
3.5
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
304
1917
1.73
15.04
2.6
2.0
s
29.8
29.9
0.02
299
1856
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
526
3823
1.57
14.73
3.5
3.2
ng/l
3064.5
1743.1
3.23
454
3278
(3000991) Gas panel - Venous blood
187
1022
1.94
14.72
12.4
8.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
66
230
2.95
14.45
4.2
3.5
%
60.0
59.1
0.19
66
230
(3019309) Folate [Moles/volume] in Red Blood Cells
378
2550
1.64
14.42
1.9
1.8
nmol/l
1302.1
1182.0
1.67
313
1895
(3024932) HLA-DR beta [Type]
21
29
7.33
14.42
1.1
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
237
1421
1.79
13.90
2.5
1.6
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
56
183
3.14
13.71
3.7
3.1
u/ml
502.3
2237.1
—
6
20
(3036481) Cortisol [Moles/volume] in Serum or Plasma
185
1037
1.89
13.46
2.1
2.0
nmol/l
371.5
373.3
0.05
175
945
(3011397) Hemoglobin [Presence] in Urine by Test strip
387
2677
1.59
13.16
5.6
3.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
240
1469
1.75
13.07
7.1
7.1
mmol/l
0.8
1.2
0.70
178
1134
(3002173) Hemoglobin [Mass/volume] in Arterial blood
203
1183
1.82
13.05
7.8
8.0
g/l
116.0
120.9
2.59
196
1138
(3018095) Leukocytes [#/volume] in Urine
574
4346
1.51
12.92
5.5
3.8
e6/l
135.5
125.2
0.10
442
3192
(3010375) cycloSPORINE [Mass/volume] in Blood
24
43
5.65
12.91
25.0
28.4
ug/l
100.2
128.5
1.26
16
33
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
590
4496
1.50
12.86
5.2
3.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
98
444
2.29
12.61
3.9
2.6
u/ml
0.3
0.4
0.75
53
255
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
499
3683
1.52
12.61
2.3
2.1
u/l
168.1
240.1
1.27
467
3464
(3037467) Urinalysis macro (dipstick) panel - Urine
980
8287
1.49
12.60
5.9
4.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
190
1097
1.83
12.57
3.4
2.6
e9/l
70.2
69.3
0.13
153
848
(3016502) Oxygen saturation in Arterial blood
217
1304
1.77
12.57
7.4
7.5
%
95.2
95.4
0.22
212
1252
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
197
1151
1.81
12.54
2.6
2.6
ug/l
7.2
6.5
0.10
174
987
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
118
584
2.10
12.21
6.2
2.6
%
0.7
0.7
0.04
113
564
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
237
1478
1.71
12.02
7.1
7.0
kpa
5.0
5.1
0.45
230
1403
(3027801) Oxygen [Partial pressure] in Arterial blood
237
1479
1.71
11.99
7.1
7.0
kpa
12.0
11.8
0.24
229
1403
(3015377) Calcium [Moles/volume] in Serum or Plasma
545
4132
1.49
11.97
3.5
3.3
mmol/l
2.3
2.4
2.73
490
3582
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
774
6289
1.46
11.90
6.0
6.1
umol/l
11.1
12.0
0.81
730
5950
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
500
3732
1.50
11.83
4.1
2.4
u/l
66.8
57.3
0.50
464
3451
(3030467) Casts [#/volume] in Urine by Automated count
467
3443
1.51
11.70
4.5
3.2
e6/l
0.4
0.5
0.52
375
2661
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1299
11754
1.64
11.61
25.4
15.4
mg/l
23.3
25.8
2.09
1102
9442
(3002582) Erythrocytes [#/volume] in Urine
505
3793
1.49
11.52
4.7
3.3
e6/l
216.3
90.0
0.53
412
2982
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
56
206
2.78
11.17
1.5
1.2
u/ml
279.8
276.4
0.03
41
119
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
161
916
1.85
11.14
2.0
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
55
201
2.80
11.10
7.7
2.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
137
741
1.93
11.08
1.6
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
86
391
2.27
11.00
1.4
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1329
12137
1.66
10.94
29.3
17.9
mmol/l
139.3
139.6
3.61
1299
11781
(3014111) Lactate [Moles/volume] in Serum or Plasma
184
1096
1.77
10.94
8.3
7.0
mmol/l
1.4
1.4
0.15
178
1049
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
58
220
2.70
10.92
1.5
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
450
3336
1.49
10.82
4.5
3.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
22
43
5.18
10.80
1.3
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1330
12165
1.65
10.68
30.0
18.0
mmol/l
4.0
4.0
2.81
1299
11793
(3031040) Bacteria [#/volume] in Urine by Automated count
939
8003
1.44
10.65
5.9
4.7
e6/l
115.4
1976.0
1.83
25
133
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
76
337
2.32
10.32
1.7
1.6
iu/ml
0.7
18.4
0.48
12
66
(3020891) Body temperature
102
513
2.06
10.13
8.7
4.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
115
604
1.98
10.13
15.0
3.7
mmol/l
23.6
24.1
1.09
99
549
(3026782) Osmolality of Urine
358
2563
1.52
10.09
3.9
2.8
mosm/kgh2o
520.7
555.7
2.43
305
2189
(3019060) Gas panel - Arterial blood
152
876
1.81
10.08
5.5
4.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1088
9576
1.45
10.05
29.0
18.6
%
14.0
13.8
3.64
1071
9348
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
49
180
2.78
9.83
1.2
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
77
354
2.24
9.62
2.2
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
633
5089
1.41
9.62
2.2
2.0
pmol/l
94.9
93.4
0.33
343
2666
(3005719) IgG [Mass/volume] in Serum or Plasma
145
840
1.80
9.45
2.8
2.9
g/l
11.3
10.6
0.46
133
764
(3028626) Oxygen [Partial pressure] in Capillary blood
71
318
2.29
9.44
2.9
3.5
kpa
8.5
8.1
1.04
66
294
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
15
23
6.58
9.36
1.1
1.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
219
1427
1.62
9.28
1.4
1.3
titre
778.5
457.5
0.93
54
300
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
36
115
3.18
9.22
1.3
1.2
u/l
48.7
53.2
0.36
27
80
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
33
100
3.35
9.19
1.2
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
63
272
2.37
9.11
5.4
3.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
140
816
1.79
8.95
9.5
6.6
mmol/l
23.9
24.5
0.89
134
761
(3020630) Protein [Mass/volume] in Serum or Plasma
171
1055
1.70
8.94
2.5
2.7
g/l
67.1
66.3
0.58
157
950
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
20
43
4.70
8.83
2.6
3.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
619
5013
1.39
8.78
4.3
2.8
ug/l
161.8
141.8
1.11
577
4564
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
225
1495
1.59
8.77
14.0
7.8
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
60
258
2.38
8.77
2.9
2.3
%
16.0
15.9
0.09
38
132
(3004775) Volume in Urine collected for unspecified duration
29
84
3.50
8.66
3.2
2.1
ml
667.1
645.0
0.09
17
53
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
21
48
4.42
8.62
1.1
1.1
ratio
1.1
1.1
—
7
16
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
135
787
1.78
8.62
9.0
8.9
%
1.4
1.4
0.07
135
780
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
24
61
3.98
8.61
1.3
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
28
80
3.55
8.54
1.4
1.1
—
—
—
0
0
(3036489) Thrombin time
82
406
2.08
8.53
2.1
2.1
s
21.1
21.3
0.14
72
366
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
22
54
4.12
8.27
1.0
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
207
1368
1.59
8.24
1.5
1.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1335
12392
1.55
8.16
28.3
17.8
umol/l
98.6
80.7
13.37
1335
12387
(3028026) IgM [Mass/volume] in Serum or Plasma
117
666
1.82
8.09
1.6
1.7
g/l
1.3
1.5
0.47
104
608
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
150
919
1.70
8.05
3.1
2.8
ml/min/173m2
55.1
63.6
1.75
75
382
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
361
2695
1.44
8.03
1.9
1.7
pmol/l
74751259.0
21155145.7
0.64
301
2217
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
53
226
2.39
7.92
8.6
1.6
nmol/l
0.8
0.9
0.21
43
187
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
141
854
1.72
7.89
4.9
3.8
kpa
5.1
5.2
0.64
129
791
(3008898) HLA-B27 [Presence]
71
344
2.11
7.83
1.2
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
139
845
1.71
7.67
4.9
3.9
ph
7.4
7.4
0.14
27
101
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
297
2157
1.47
7.59
2.0
1.9
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
130
780
1.73
7.53
9.3
9.1
%
93.6
93.8
0.18
130
773
(46235355) HIV 1 and 2 tests - Meaningful Use set
244
1712
1.50
7.39
2.7
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
346
2601
1.42
7.33
6.2
4.1
kg/l
1.0
1.0
0.67
40
391
(3041096) Erythrocytes [Presence] in Urine by Automated
408
3168
1.39
7.15
4.4
3.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
141
880
1.66
7.06
2.2
2.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
132
814
1.68
6.92
4.8
3.8
mmol/l
1.0
1.8
1.07
89
600
(40758558) Short blood count panel - Blood
380
2930
1.39
6.92
8.6
6.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
160
1038
1.60
6.87
6.0
3.5
—
—
—
0
0
(3044889) 12 lead EKG panel
937
8283
1.33
6.81
4.5
4.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1322
12351
1.47
6.75
15.8
10.3
u/l
25.5
25.9
0.25
1279
11872
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
43
180
2.43
6.73
1.4
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1156
10555
1.37
6.71
5.4
4.6
mu/l
2.0
2.1
0.52
1051
9532
(3015235) Bicarbonate [Moles/volume] in Capillary blood
68
347
2.00
6.58
3.2
3.0
mmol/l
24.2
24.9
0.62
60
303
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
214
1498
1.50
6.53
1.9
1.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
399
3127
1.37
6.53
3.4
2.7
umol/l
4463.6
6989.3
0.57
338
2683
(3028433) Virus identified in Specimen by Culture
16
37
4.36
6.50
1.2
1.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
74
392
1.93
6.44
6.9
3.9
mmol/l
4.1
3.9
1.20
68
364
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
10
15
6.70
6.31
1.0
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
38
845
0.44
6.29
1.9
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
64
326
2.00
6.24
1.5
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
52
247
2.14
6.10
2.9
2.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
329
2529
1.38
6.01
1.9
1.7
mg/l
1.5
1.2
0.84
270
1946
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
210
1494
1.47
5.90
1.9
1.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
309
2362
1.38
5.83
3.3
3.1
mmol/l
2.5
2.5
0.86
272
2053
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
35
143
2.48
5.80
1.2
1.2
u/ml
2.2
5.2
1.20
13
69
(3027135) IgG subclass 1 [Mass/volume] in Serum
26
91
2.89
5.79
1.4
1.3
g/l
6.9
6.4
0.26
17
64
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
35
144
2.46
5.72
1.2
1.2
u/ml
3.5
4.8
0.18
15
51
(40761536) Microorganisms panel - Urine sediment
153
1026
1.54
5.71
5.5
3.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
968
8704
1.30
5.66
4.5
3.8
pmol/l
15.2
14.9
2.48
868
7810
(3021960) Folate [Moles/volume] in Serum or Plasma
380
3017
1.34
5.61
1.6
1.6
nmol/l
19.9
20.3
0.14
332
2557
(3006184) Hemoglobin [Mass/volume] in Capillary blood
54
271
2.03
5.51
2.1
2.0
g/l
125.5
128.4
0.31
47
204
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
107
665
1.65
5.49
8.2
10.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
44
873
0.49
5.35
1.3
1.4
—
—
—
0
0
(3016750) Collection duration of Urine
20
63
3.20
5.32
3.6
2.1
min
496.5
500.7
0.08
13
43
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
19
58
3.30
5.31
1.2
1.1
u/l
102.8
77.6
0.59
13
43
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
19
58
3.30
5.31
1.2
1.1
u/l
43.5
22.8
0.69
13
41
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1159
10717
1.32
5.28
9.1
5.6
mmol/mol
45.5
39.7
33.51
1065
9824
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
22
74
3.00
5.27
1.9
1.6
u/l
1.8
7.8
1.33
12
37
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
27
102
2.68
5.25
1.5
1.6
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
25
91
2.78
5.21
1.5
1.3
g/l
0.4
0.3
0.21
15
61
(3028192) IgG subclass 2 [Mass/volume] in Serum
25
91
2.78
5.21
1.4
1.3
g/l
2.9
2.6
0.31
16
64
(3012501) Base excess in Blood by calculation
54
277
1.98
5.21
7.3
4.8
mmol/l
2.6
2.7
0.09
41
191
(4306422)
33
139
2.40
5.16
1.3
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
106
669
1.63
5.13
7.7
9.4
mmol/l
23.6
24.5
2.13
96
615
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
23
576
0.39
5.12
1.5
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
273
2091
1.37
5.04
3.6
2.8
e6/l
1.0
1.3
0.56
168
1223
(4062490)
25
93
2.72
5.02
1.5
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
52
267
1.98
5.01
8.1
3.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
52
268
1.97
4.96
1.9
2.2
u/l
3132.1
2992.8
0.02
14
107
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
20
66
3.06
4.95
1.5
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
20
66
3.06
4.95
1.5
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1362
12947
1.42
4.91
36.7
22.4
e9/l
248.8
244.5
1.54
1336
12575
(3024731) MCV [Entitic volume]
1362
12950
1.42
4.87
36.6
22.3
fl
91.6
91.3
1.41
1343
12710
(3035941) MCH [Entitic mass]
1362
12951
1.42
4.86
36.6
22.3
pg
30.3
30.4
0.36
1343
12708
(3026361) Erythrocytes [#/volume] in Blood
1362
12952
1.42
4.85
36.8
22.4
e12/l
4.3
4.5
9.31
1329
12535
(40760888) Immunoglobulin light chains.free panel - Serum
56
299
1.91
4.83
2.7
3.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
56
299
1.91
4.83
1.4
1.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
25
95
2.66
4.83
2.0
2.2
e9/l
1.1
1.1
0.06
16
56
(3010813) Leukocytes [#/volume] in Blood
1362
12956
1.41
4.80
36.8
22.4
e9/l
7.0
6.8
1.48
1329
12536
(3000963) Hemoglobin [Mass/volume] in Blood
1362
12956
1.41
4.80
37.0
22.5
g/l
130.9
134.3
11.93
1346
12712
(3025315) Body weight
8
7
11.48
4.78
5.8
4.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
9
10
9.04
4.78
1.1
1.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
49
251
1.98
4.77
1.8
1.3
e6/l
20.4
40.8
0.32
37
199
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
49
251
1.98
4.77
1.8
1.4
e6/l
190.8
782.5
0.73
39
206
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
90
557
1.65
4.72
2.1
1.9
ug/l
2.4
1.7
0.24
82
476
(3019832) Treponema pallidum Ab [Presence] in Serum
121
807
1.54
4.66
1.7
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
56
303
1.88
4.66
1.9
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
70
408
1.75
4.58
3.4
3.6
mg/l
100.6
66.5
0.52
53
340
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
59
327
1.84
4.56
1.8
1.6
—
—
—
0
0
(3010421) pH of Blood
61
342
1.82
4.54
7.8
4.4
ph
7.4
7.4
1.55
53
273
(3044290) Cell count panel - Cerebral spinal fluid
43
214
2.04
4.54
1.8
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
44
221
2.02
4.54
1.5
1.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
231
1752
1.37
4.52
29.0
28.1
inr
1.5
1.4
0.44
34
229
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
70
410
1.74
4.51
3.3
3.6
mg/l
54.2
70.7
0.23
52
343
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1170
10911
1.29
4.50
22.5
14.2
ml/min/173m2
72.9
78.0
8.88
1001
9019
(3036603) Volume of Urine
20
70
2.88
4.50
2.5
1.5
ml
1598.0
1767.6
—
6
16
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
32
142
2.28
4.49
1.5
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
31
136
2.31
4.47
1.3
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
98
630
1.59
4.43
1.5
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
33
150
2.23
4.39
1.3
1.4
e6/l
17088.7
72353.5
0.75
18
89
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
14
40
3.52
4.33
1.1
1.1
miu/ml
2333.9
1567.3
1.45
14
40
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
183
1345
1.41
4.32
2.8
2.7
umol/l
6.9
9.3
0.92
153
1162
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
40
201
2.02
4.14
1.9
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
42
215
1.98
4.13
1.3
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
266
2090
1.33
4.13
1.6
1.4
g/l
2.6
2.5
0.08
171
1253
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
49
266
1.87
4.07
1.1
1.3
miu/ml
158.6
244.1
0.52
12
115
(3023199) Leukocytes [#/volume] in Pleural fluid
35
169
2.10
4.03
1.3
1.4
e6/l
1700.6
1445.4
0.16
25
120
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
73
447
1.66
4.03
2.3
2.7
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
17
58
2.95
4.01
2.3
2.9
u/ml
644.5
1473.7
1.11
17
58
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
159
1156
1.42
4.00
1.9
2.3
g/l
0.2
0.2
0.77
146
1076
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
28
3.95
3.98
1.7
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
43
226
1.93
3.94
1.4
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
12
33
3.66
3.92
1.4
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
76
2.65
3.90
1.5
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
633
5564
1.23
3.89
5.7
4.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
35
172
2.06
3.87
1.3
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
37
186
2.01
3.85
1.3
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
66
2.75
3.76
2.0
2.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
54
311
1.76
3.73
1.4
1.7
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
41
217
1.91
3.70
1.2
1.2
—
33.3
—
0
6
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
33
162
2.06
3.67
1.3
1.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
16
5.65
3.66
1.0
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
9
16
5.65
3.66
1.0
1.2
%
81.9
96.3
—
9
16
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
30
3.69
3.64
1.1
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1277
12142
1.29
3.61
24.4
14.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
140
1015
1.42
3.59
9.0
3.6
mmol/l
1.2
1.2
0.80
127
874
(3026389) Candida sp identified in Specimen by Organism specific culture
30
144
2.10
3.54
1.5
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
32
158
2.05
3.51
1.5
1.5
g/l
0.4
0.7
2.44
23
119
(3028271) Lactate [Moles/volume] in Capillary blood
38
203
1.89
3.36
2.3
1.9
mmol/l
1.5
1.6
0.23
38
198
(3036525) Urea [Moles/time] in 24 hour Urine
6
7
8.60
3.26
4.5
5.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
56
340
1.67
3.25
1.4
1.4
ug/g
257.2
294.4
0.77
34
204
(3011648) Oxygen content in Venous blood
21
91
2.33
3.18
4.1
3.4
%
11.3
11.2
0.04
21
91
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
110
785
1.43
3.11
1.7
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
46
269
1.73
3.07
1.5
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
26
126
2.08
3.03
2.1
2.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
12
5.85
3.02
2.0
1.3
ng/l
91.6
88.5
—
7
12
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
34
182
1.89
3.02
1.4
1.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
17
69
2.48
2.96
1.8
2.3
%
13.0
15.9
—
7
34
(3012441) Differential panel - Pleural fluid
28
141
2.00
2.96
1.4
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
108
776
1.42
2.95
2.9
3.0
e9/l
4.1
4.1
0.00
84
586
(3023420) DNA double strand Ab [Units/volume] in Serum
22
102
2.17
2.87
1.8
1.4
—
35.3
—
0
6
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
12
41
2.94
2.86
1.1
1.1
—
20.8
—
0
6
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
46
276
1.69
2.83
1.5
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
31
3.24
2.77
1.2
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
290
2421
1.24
2.76
4.8
4.0
ng/l
595.9
345.1
0.29
250
1981
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
6
8.35
2.75
1.2
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
440
3838
1.20
2.72
3.4
2.4
—
—
—
0
0
(3019977) pH of Arterial blood
16
66
2.44
2.71
3.1
3.6
ph
7.4
7.4
—
5
17
(3037121) Protein [Mass/volume] in Urine
67
446
1.52
2.71
4.0
3.2
g/l
0.4
0.3
0.98
40
172
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
19
4.23
2.68
1.1
2.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
342
2917
1.22
2.66
3.3
2.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
98
708
1.41
2.63
4.2
2.6
e6/l
0.3
0.3
0.11
98
689
(3038071) Oxygen [Partial pressure] in Mixed venous blood
9
25
3.61
2.57
71.8
7.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
25
3.61
2.57
1.2
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
342
2929
1.21
2.55
1.9
1.6
mmol/l
1.4
1.4
0.13
282
2464
(3013512) EKG study
412
3592
1.20
2.55
5.1
4.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
26
136
1.93
2.51
6.3
2.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
24
122
1.98
2.51
1.9
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
77
538
1.45
2.49
4.6
4.8
%
1.5
1.6
0.18
71
505
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
39
2.83
2.47
3.5
3.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
39
2.83
2.47
3.5
3.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
22
109
2.03
2.46
1.1
1.4
%
38.7
28.1
—
9
71
(3047189) Immunofixation for 24 hour Urine
15
63
2.39
2.46
1.7
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
21
103
2.05
2.42
2.4
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
34
2.95
2.41
1.6
1.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
23
117
1.98
2.41
1.8
1.3
nmol/l
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
12
5.01
2.40
1.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
27
3.35
2.39
71.9
7.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
41
251
1.65
2.38
1.8
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
20
97
2.08
2.37
1.0
1.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
58
387
1.52
2.36
1.3
1.2
u/ml
0.4
1.3
—
7
25
(3047181) Lactate [Moles/volume] in Blood
60
404
1.50
2.34
5.2
5.9
mmol/l
1.2
1.4
1.32
52
353
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1208
11566
1.20
2.33
5.8
4.8
mmol/l
2.5
2.7
13.71
1111
10506
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
86
622
1.41
2.32
4.1
3.5
pmol/l
4.4
4.5
0.53
79
545
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
140
1094
1.31
2.30
4.3
2.3
u/l
59.1
81.2
0.19
116
933
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
13
4.63
2.27
1.2
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
13
4.63
2.27
1.2
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
15
66
2.29
2.24
1.9
1.6
—
42.3
—
0
6
(3003181) Sodium [Moles/volume] in Urine
38
232
1.65
2.24
1.2
1.3
mmol/l
58.5
62.9
0.28
30
189
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
276
2343
1.22
2.24
1.4
1.2
u/ml
1.7
1.6
0.04
90
608
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
22
115
1.93
2.16
1.4
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
44
283
1.57
2.13
1.3
1.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
74
531
1.41
2.11
6.3
4.4
mmol/l
23.5
24.8
2.71
68
491
(4268621)
19
95
2.01
2.11
2.2
2.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
25
3.21
2.09
2.5
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
84
618
1.38
2.08
2.8
2.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
27
456
0.58
2.07
1.7
1.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
74
533
1.41
2.07
5.0
4.8
%
0.8
0.9
0.93
68
501
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
236
1990
1.22
2.06
3.9
3.0
e6/l
2.2
2.3
0.02
132
1129
(3000093) Morphology [Interpretation] in Blood Narrative
20
103
1.95
2.05
1.1
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
26
3.09
2.01
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
50
336
1.50
2.01
1.2
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
229
0.43
1.96
1.2
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
22
120
1.85
1.93
1.2
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
142
1141
1.27
1.92
2.9
3.0
ng/l
321.3
230.9
1.00
130
1045
(4146454)
22
121
1.83
1.89
3.8
2.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
52
0.00
1.88
0.0
1.1
—
1.5
—
0
20
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
34
2.66
1.86
2.0
2.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
223
0.44
1.85
1.4
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
154
1258
1.25
1.82
2.3
2.3
ug/g
128.1
133.4
0.08
117
1002
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
14
66
2.13
1.82
1.1
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
53
369
1.45
1.81
3.8
3.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
71
522
1.38
1.80
2.0
1.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
29
177
1.65
1.77
2.3
2.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
465
1.39
1.75
2.4
2.5
g/l
11.0
10.5
0.44
55
392
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
18
3.34
1.74
1.0
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
188
1577
1.22
1.74
1.2
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
23
132
1.75
1.74
1.4
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
30
2.68
1.72
1.6
1.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
11
48
2.30
1.70
1.2
1.1
iu/ml
170.2
246.6
0.48
11
48
(3023410) Appearance of Cerebral spinal fluid
21
118
1.79
1.70
2.6
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
82
623
1.33
1.70
5.7
4.0
—
—
—
0
0
(3004451) EKG impression Narrative
14
68
2.07
1.70
1.4
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
29
179
1.63
1.70
2.6
2.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1175
11319
1.16
1.69
5.3
4.3
mmol/l
4.3
4.6
12.15
1080
10369
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
42
2.39
1.68
1.0
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
40
268
1.51
1.67
3.8
3.6
mg/l
35.7
26.8
0.61
27
176
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
16
83
1.94
1.64
2.2
2.1
e6/l
721.7
689.9
—
8
33
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1165
11226
1.15
1.63
5.3
4.3
mmol/l
1.4
1.4
3.15
1066
10201
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
25
151
1.67
1.60
1.3
1.5
%
37.1
63.6
—
10
100
(3017704) Immunofixation for Urine
15
77
1.96
1.59
1.2
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1128
10857
1.14
1.56
4.8
3.9
mmol/l
1.3
1.3
1.51
1025
9801
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
19
107
1.79
1.55
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
24
145
1.67
1.54
1.5
1.6
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
14
71
1.98
1.54
1.3
1.1
mg/l
41.6
35.5
—
9
58
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
44
2.28
1.53
4.5
2.8
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
21
2.86
1.50
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
39
267
1.47
1.49
2.3
1.8
iu/l
3.1
5.0
1.13
15
86
(4027681)
12
58
2.08
1.49
1.6
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
38
259
1.48
1.49
1.4
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
19
110
1.74
1.43
1.6
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
32
213
1.51
1.41
1.2
1.3
u/l
24.0
45.9
1.07
26
185
(3003338) MCHC [Mass/volume]
1015
9737
1.12
1.38
32.6
19.7
g/l
330.8
332.2
5.12
1003
9634
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
12
60
2.01
1.38
3.0
3.9
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
38
265
1.44
1.35
2.0
3.1
umol/l
33.9
35.6
0.10
30
219
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
497
1.32
1.34
2.4
2.4
g/l
3.8
3.8
0.15
49
355
(3044242) Glucose [Moles/volume] in Arterial blood
14
75
1.87
1.34
1.6
2.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
53
393
1.36
1.34
2.7
2.4
g/l
36.5
37.4
0.45
47
335
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
45
325
1.40
1.33
1.8
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
498
1.32
1.33
2.4
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
498
1.32
1.33
2.4
2.4
g/l
7.9
7.4
1.57
49
369
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
19
113
1.69
1.32
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
19
113
1.69
1.32
1.4
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
711
6702
1.11
1.31
2.8
2.8
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
24
2.51
1.30
1.3
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
46
335
1.38
1.30
1.3
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
16
91
1.77
1.29
1.0
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
145
1226
1.20
1.29
1.3
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
14
77
1.83
1.25
1.6
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
26
171
1.53
1.23
1.2
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
97
1181
0.81
1.23
1.6
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
63
1.91
1.23
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
46
339
1.37
1.22
1.3
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
11
56
1.97
1.22
1.3
1.1
u/l
1.1
1.1
—
5
28
(4034850)
51
383
1.34
1.21
24.6
10.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
78
1.80
1.21
2.5
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
14
78
1.80
1.21
1.6
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
42
306
1.38
1.20
1.5
1.7
e6/l
9521.3
16871.4
0.90
30
223
(3003327) Ova and parasites identified in Stool by Light microscopy
45
333
1.36
1.18
1.5
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
57
1.94
1.17
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
57
1.94
1.17
1.0
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
14
79
1.78
1.17
3.3
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
46
343
1.35
1.15
1.3
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
20
2.50
1.15
1.2
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
55
422
1.31
1.14
2.8
2.7
g/l
0.8
1.4
0.47
46
365
(3004809) Band form neutrophils/100 leukocytes in Blood
31
216
1.44
1.14
3.4
3.5
%
1.1
1.5
0.32
25
170
(3017569) Oxygen content in Arterial blood
12
65
1.85
1.13
1.8
2.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
7
30
2.34
1.12
3.3
1.5
—
—
—
0
0
(44806420)
8
41
1.96
1.09
2.1
2.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
41
1.96
1.09
1.0
1.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
462
1.29
1.07
2.5
2.5
g/l
3.3
3.1
0.41
49
361
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
33
2.13
1.05
1.3
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
779
7433
1.10
1.05
3.3
3.1
u/l
53.3
50.3
0.37
718
6876
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
24
347
0.69
1.04
1.5
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
48
369
1.31
1.01
1.5
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
160
0.56
0.98
1.4
1.6
—
—
—
0
0
(3019225) pH of Specimen
140
1214
1.17
0.97
7.8
4.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
241
2666
0.89
0.97
3.1
3.1
ug/l
0.9
0.8
0.36
175
1806
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
50
1.80
0.96
1.7
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
50
1.80
0.96
1.7
2.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
26
182
1.44
0.96
1.7
1.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
62
1.78
0.94
1.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
7
37
1.90
0.94
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
46
356
1.30
0.94
5.4
5.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
27
2.23
0.93
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
27
2.23
0.93
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
27
2.23
0.93
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
27
2.23
0.93
1.2
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
52
1.73
0.92
1.7
2.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
28
201
1.40
0.91
1.4
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
28
2.15
0.91
1.0
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
39
297
1.32
0.89
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
39
297
1.32
0.89
1.3
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
22
152
1.45
0.88
3.6
4.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
17
111
1.54
0.87
1.6
2.4
u/field
2.1
2.1
0.01
11
41
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
146
1283
1.15
0.87
1.4
1.8
%
1.6
1.5
0.37
127
1103
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
8
43
1.86
0.87
1.8
1.7
nmol/l
2.7
5.8
—
8
34
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
30
2.00
0.87
3.0
2.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
486
4579
1.09
0.84
2.2
2.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
62
507
1.23
0.83
2.0
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
19
129
1.48
0.83
1.4
1.9
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
14
214
0.65
0.83
2.0
1.9
pmol/l
187.2
217.3
0.69
14
202
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
190
0.63
0.83
1.1
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
190
0.63
0.83
1.1
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
21
296
0.71
0.83
1.7
1.7
nmol/l
48.0
40.0
0.67
21
284
(21494434) Karyotype in Bone marrow
18
121
1.49
0.82
1.0
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
6
115
0.52
0.82
1.7
1.5
u/l
17.4
25.4
—
6
97
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
189
0.63
0.81
1.1
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
189
0.63
0.81
1.1
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
97
1.55
0.81
1.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
22
155
1.43
0.81
1.7
2.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
47
1.71
0.80
1.1
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
13
200
0.65
0.80
1.2
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
78
657
1.20
0.79
4.2
3.9
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
33
1.82
0.79
1.0
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
98
1.54
0.78
1.5
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
27
199
1.36
0.78
1.7
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
186
1676
1.12
0.78
1.4
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
21
292
0.72
0.78
1.2
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
18
123
1.47
0.77
1.2
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
59
1.70
0.76
1.1
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
13
83
1.57
0.75
1.5
1.4
mmol/l
7.0
11.4
—
5
19
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
66
551
1.21
0.75
2.2
1.9
—
—
—
0
0
(4133840)
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
38
1.85
0.73
1.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
176
1.37
0.73
1.1
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
39
1.80
0.72
1.0
2.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
10
60
1.67
0.72
1.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
60
1.67
0.72
1.1
1.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
19
134
1.42
0.71
1.4
1.4
mmol/l
6.4
6.5
0.07
19
126
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
198
1806
1.11
0.69
1.3
1.3
iu/ml
45.3
34.6
0.31
53
569
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
12
77
1.56
0.68
2.2
3.0
%
50.8
38.7
—
5
25
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
61
1.64
0.68
1.7
1.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
10
61
1.64
0.68
2.4
1.4
ug/l
10.7
6.6
—
10
53
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
61
1.64
0.68
1.7
1.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
16
110
1.46
0.68
1.2
1.2
nmol/l
460.7
367.5
0.71
11
94
(3024263) Appearance of Synovial fluid
11
69
1.60
0.68
1.5
1.6
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
7
42
1.67
0.68
1.0
1.4
mmol/l
2.6
3.6
—
7
36
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
22
161
1.37
0.68
1.8
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
22
161
1.37
0.68
1.8
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
22
161
1.37
0.68
1.8
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
23
307
0.75
0.68
3.3
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
119
0.59
0.67
1.3
1.5
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
24
179
1.35
0.67
2.0
5.2
umol/l
281.3
360.3
2.24
18
156
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
17
119
1.43
0.67
1.5
1.9
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
7
43
1.63
0.67
1.1
1.3
%
21.6
26.9
—
7
38
(3004716) Salmonella sp identified in Stool by Organism specific culture
62
522
1.20
0.66
1.3
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
22
162
1.36
0.66
1.8
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
22
162
1.36
0.66
1.8
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1154
11311
1.08
0.65
5.2
4.5
mmol/l
6.6
5.9
19.65
1033
10177
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
22
163
1.35
0.64
1.8
1.5
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
14
95
1.48
0.64
1.9
2.3
mmol/l
7.9
6.7
—
9
59
(3023430) Cat dander IgE Ab [Units/volume] in Serum
15
104
1.45
0.62
1.0
1.1
u/ml
1.5
3.5
—
6
41
(40768795) Lymph node Pathology biopsy report
6
102
0.59
0.62
1.5
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
103
0.58
0.62
1.0
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
93
818
1.15
0.60
2.0
1.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
80
1.50
0.60
1.1
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
142
1285
1.12
0.59
3.0
4.1
ug/l
25.5
22.4
0.08
113
1077
(3017354) Segmented neutrophils/100 leukocytes in Blood
19
140
1.36
0.58
3.6
3.5
%
60.8
54.1
0.60
13
100
(3003740) Influenza virus B Ag [Presence] in Specimen
10
150
0.66
0.58
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
20
149
1.35
0.58
1.3
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
132
1459
0.90
0.57
5.8
4.4
%
33.2
32.7
0.20
89
955
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
29
364
0.79
0.57
2.1
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
44
365
1.21
0.57
1.6
1.8
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
36
1.67
0.56
1.5
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
149
0.67
0.56
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1071
10500
1.06
0.54
25.5
16.5
%
38.0
39.4
3.83
664
7199
(3014051) Protein [Presence] in Urine by Test strip
34
277
1.23
0.53
2.1
2.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
33
268
1.24
0.52
1.3
1.2
u/ml
3.3
12.2
—
6
45
(3038026) Centromere Ab [Units/volume] in Serum
12
83
1.45
0.52
1.1
1.1
—
100.4
—
0
5
(40768793) Breast Pathology biopsy report
19
248
0.76
0.51
1.3
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
22
170
1.30
0.51
1.1
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
64
1.41
0.51
2.6
3.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
157
0.70
0.51
1.1
1.5
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
75
1.47
0.50
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
75
1.47
0.50
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
75
1.47
0.50
1.3
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
144
0.69
0.49
1.9
1.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
76
1.45
0.48
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
76
1.45
0.48
1.3
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
76
1.45
0.48
2.3
2.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
76
1.45
0.48
1.3
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
25
310
0.80
0.47
3.1
1.7
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
48
1.46
0.46
1.7
3.2
u/l
254.1
211.0
—
7
48
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
32
264
1.22
0.46
1.3
1.2
u/ml
1.5
2.8
—
6
26
(3023323) Follitropin [Units/volume] in Serum or Plasma
44
375
1.18
0.45
1.2
1.4
iu/l
28.8
26.3
0.19
38
317
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
153
0.72
0.45
1.1
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
152
0.72
0.44
1.1
1.4
—
—
—
0
0
(4035726)
111
1012
1.10
0.44
1.4
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
88
792
1.12
0.44
3.3
3.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
140
0.71
0.43
1.5
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
63
556
1.14
0.43
2.6
2.7
—
—
—
0
0
(3035880) pH of Pleural fluid
12
87
1.38
0.42
1.2
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
58
1.38
0.41
27.4
13.8
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
33
1.52
0.41
1.8
1.6
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
59
1.36
0.41
7.4
7.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
11
79
1.40
0.40
1.3
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
79
1.40
0.40
1.3
1.3
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
17
0.00
0.40
0.0
1.0
—
9.0
—
0
6
(3006653) Thiamine [Moles/volume] in Blood
8
60
1.34
0.40
1.1
1.2
nmol/l
141.1
142.7
—
8
60
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
18
0.00
0.40
0.0
1.2
—
26.5
—
0
12
(4281824)
7
105
0.67
0.39
2.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
24
291
0.82
0.38
3.2
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
52
457
1.14
0.38
1.7
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
322
3080
1.06
0.38
1.4
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
68
1.33
0.37
1.7
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
68
1.33
0.37
1.7
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
68
1.33
0.37
1.7
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
68
1.33
0.37
1.7
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
26
311
0.83
0.37
3.1
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
86
942
0.91
0.36
1.7
2.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
356
3702
0.95
0.36
4.6
4.4
%
23.1
21.6
0.82
183
1854
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
19
153
1.24
0.35
1.1
1.0
u/ml
1.5
2.2
—
6
58
(3000764) Benzodiazepines [Presence] in Urine
26
309
0.84
0.35
3.0
1.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
44
1.37
0.34
1.0
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
11
82
1.34
0.34
1.0
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
25
210
1.19
0.32
2.0
1.6
—
—
—
0
0
(44806118)
18
146
1.24
0.32
1.2
1.6
—
—
—
0
0
(44790048)
18
146
1.24
0.32
1.2
1.6
—
—
—
0
0
(44790047)
18
146
1.24
0.32
1.2
1.6
—
—
—
0
0
(44790049)
18
146
1.24
0.32
1.2
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
473
4592
1.04
0.32
4.8
5.1
ug/l
2.9
4.3
0.74
419
4087
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
75
1.34
0.30
1.7
1.6
g/l
0.8
1.0
—
10
75
(3010144) Erythrocytes [#/volume] in Synovial fluid
15
120
1.25
0.30
1.2
1.4
e6/l
2303.1
162956.9
—
8
80
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
55
1.27
0.30
2.6
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
56
1.25
0.29
1.0
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
46
513
0.89
0.29
1.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
76
1.32
0.28
3.9
3.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
94
1.28
0.28
1.3
1.1
—
—
—
0
0
(4094501)
25
290
0.86
0.27
1.1
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
48
433
1.11
0.26
1.1
1.1
—
2.0
—
0
6
(3027456) Digoxin [Moles/volume] in Serum or Plasma
31
352
0.88
0.26
2.8
3.1
nmol/l
0.8
0.8
0.02
18
276
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
267
0.86
0.26
1.1
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
72
1.25
0.25
2.6
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
72
1.25
0.25
2.6
1.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
13
159
0.82
0.24
1.0
1.1
g/l
1.6
1.5
0.45
13
145
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
81
868
0.93
0.24
1.4
1.4
—
—
—
0
0
(4015189)
5
38
1.32
0.23
2.2
2.0
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
19
162
1.17
0.23
1.1
1.1
u/ml
0.2
1.8
—
8
71
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
32
287
1.12
0.21
1.2
1.2
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.1
—
875.7
—
0
5
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
25
282
0.88
0.20
1.6
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
50
1.20
0.19
1.2
1.0
—
—
—
0
0
(4024509)
12
99
1.21
0.19
1.7
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
17
147
1.16
0.18
1.1
1.0
u/ml
5.2
5.0
—
9
77
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
21
185
1.14
0.18
1.2
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
66
0.76
0.17
2.4
2.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
73
692
1.06
0.15
1.1
1.2
iu/ml
183.2
157.7
0.10
26
268
(3032773) Endomysium IgG Ab [Titer] in Serum
12
102
1.18
0.15
1.2
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
9
83
1.08
0.14
2.1
1.5
promille
1.8
1.3
—
9
65
(3025130) Human papilloma virus identified in Specimen
8
98
0.82
0.13
2.9
1.7
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
15
132
1.14
0.13
1.5
1.9
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
85
1.18
0.12
2.7
2.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
17
153
1.11
0.11
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
49
465
1.06
0.11
2.1
3.3
u/ml
60.7
8847.5
0.84
40
392
(3014271) Vancomycin [Susceptibility]
10
86
1.16
0.11
5.2
3.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
54
515
1.05
0.10
1.2
1.2
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
5
44
1.14
0.10
5.0
2.5
e6/l
257.0
631.1
—
5
37
(4010399)
86
832
1.04
0.09
1.6
1.4
—
—
—
0
0
(1002224) Polysomnography panel
38
401
0.95
0.09
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
28
262
1.07
0.09
1.3
1.3
—
—
—
0
0
(3000492) Spirometry study
102
1049
0.97
0.09
1.4
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
37
390
0.95
0.09
1.5
1.8
mg/l
3.9
2.9
0.48
26
293
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
18
165
1.09
0.08
1.4
2.6
u/ml
3.1
31.4
0.64
18
158
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
83
856
0.97
0.08
1.6
1.9
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
15
164
0.91
0.08
1.8
2.3
mg/l
33.6
26.7
—
5
40
(3009214) Lutropin [Units/volume] in Serum or Plasma
24
256
0.94
0.07
1.3
1.4
u/l
15.3
9.5
0.95
16
200
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
81
0.86
0.07
1.0
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
9
84
1.07
0.07
1.2
1.6
—
71.9
—
0
7
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
118
1.10
0.07
1.5
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
118
1.10
0.07
1.5
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
118
1.10
0.07
1.5
1.7
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
8
90
0.89
0.06
1.0
1.0
mg/l
314.5
288.4
—
8
82
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
142
0.91
0.06
1.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
379
3821
0.99
0.05
3.7
2.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
159
1.07
0.05
1.1
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
13
121
1.08
0.03
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
22
210
1.05
0.03
1.1
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
15
141
1.06
0.03
1.0
1.1
u/ml
0.3
1.8
—
7
64
(3017446) Testosterone [Moles/volume] in Serum or Plasma
87
884
0.98
0.03
1.9
2.1
nmol/l
11.9
12.6
0.29
75
779
(1001926) Buprenorphine [Presence] in Urine by Screen method
23
240
0.96
0.03
2.7
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
14
132
1.06
0.02
3.5
3.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
32
329
0.97
0.02
1.1
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
48
489
0.98
0.02
3.5
3.0
u/ml
22.1
65.7
3.18
43
470
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
103
1.07
0.02
1.1
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
82
829
0.99
0.01
1.2
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
151
1519
0.99
0.01
1.2
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
136
1368
0.99
0.01
1.4
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
124
0.97
0.00
3.8
3.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
146
1.03
0.00
3.7
2.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
142
0.99
0.00
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
21
209
1.00
0.00
4.0
2.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
173
1728
1.00
0.00
1.3
1.2
u/ml
23.0
12.6
0.64
68
632
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
19
193
0.98
0.00
1.2
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
68
677
1.00
0.00
1.2
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
14
145
0.97
0.00
1.6
1.3
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
4.3
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.2
—
0
5
(3040893) Potassium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
1.7
—
4.1
—
0
6
(40758358) Immune stain study
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4038314)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
54
0.93
0.00
1.0
1.3
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
0.1
—
0
8
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
6.0
—
0
8
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
6
60
1.00
0.00
1.3
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint DM_NEOVASCULAR_GLAUCOMA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| DM_NEOVASCULAR_GLAUCOMA | 1.487 [1.34, 1.65] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.06 |
During the follow-up period (1.1.1998 — 31.12.2019), 2304 out of 5718 females with DM_NEOVASCULAR_GLAUCOMA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| DM_NEOVASCULAR_GLAUCOMA | 1.544 [1.37, 1.74] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.012 |
During the follow-up period (1.1.1998 — 31.12.2019), 2217 out of 5865 males with DM_NEOVASCULAR_GLAUCOMA died.
Mortality risk
Mortality risk for people of age
years, who have DM_NEOVASCULAR_GLAUCOMA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.122% | 0.325% |
| 5 | 0.783% | 1.768% |
| 10 | 1.893% | 4.415% |
| 15 | 3.686% | 8.414% |
| 20 | 6.273% | 14.365% |
Relationships between endpoints
↥Index endpoint: DM_NEOVASCULAR_GLAUCOMA – Neovascular glaucoma
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data